Amylyx Pharmaceuticals, Inc. - Common Stock

Share · US03237H1014 · AMLX (XNAS)

Overview

Analyst Grade Summary

Buy

Strong Buy

Buy

Hold

Sell

Strong Sell

No Price

06.03.2026 21:00

Current Prices from Amylyx Pharmaceuticals, Inc. - Common Stock

Exchange	Ticker	Currency	Last Trade	Price	Daily Change
NASDAQ	AMLX	USD	06.03.2026 21:00	13,85 USD	-0,25 USD -1,77 %
IEX	AMLX	USD	06.03.2026 20:59	13,87 USD	-0,23 USD -1,67 %

Share Float & Liquidity

Free Float 66,48 %

Shares Float 55,26 M

Shares Outstanding 83,13 M

Company Profile for Amylyx Pharmaceuticals, Inc. - Common Stock Share

Amylyx Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, engages in developing various therapeutics for amyotrophic lateral sclerosis (ALS) and other neurodegenerative diseases. The company's product pipeline includes AMX0035, a dual UPR-Bax apoptosis inhibitor composed of sodium phenylbutyrate and taurursodiol for the treatment of amyotrophic lateral sclerosis. It is also developing AMX0035 for other neurodegenerative diseases. The company was founded in 2013 and is headquartered in Cambridge, Massachusetts.

AI Analysis of Amylyx Pharmaceuticals, Inc. - Common Stock

Click any analysis below to get instant AI insights from finAgent

Latest AI Analyses of Amylyx Pharmaceuticals, Inc. - Common Stock

No AI threads available for this company yet.

Company Data

Name Amylyx Pharmaceuticals, Inc. - Common Stock

Company Amylyx Pharmaceuticals, Inc.

Symbol AMLX

Website https://amylyx.com

Primary Exchange

NASDAQ

ISIN US03237H1014

Asset Class Share

Sector Healthcare

Industry Biotechnology

CEO Joshua B. Cohen

Market Capitalization 1 Mrd.

Country United States of America

Currency USD

Employees 0,1 T

Address 43 Thorndike Street, 02141 Cambridge

IPO Date 2022-01-07

Dividends from 'Amylyx Pharmaceuticals, Inc. - Common Stock'

Ex-Date	Dividend per Share
28.03.2018	0,42 USD
28.12.2017	0,36 USD
28.09.2017	0,24 USD

Ticker Symbols

Name	Symbol
NASDAQ	AMLX

More Shares

Investors who hold Amylyx Pharmaceuticals, Inc. - Common Stock also have the following shares in their portfolio:

BRISTOL-MYERS 19/22 FLR Bond

Kanemi Co., Ltd. Share

The financial platform MoneyPeak tracks and analyzes investments and portfolios. From securities portfolios to crypto purchases.
Useful, simple, and free. Stocks, ETFs, ETCs, ETNs, indices, funds, bonds, certificates, currencies, options, rights issue.

Imprint Data Protection Blog Community Feedback Changelog